Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome
- PMID: 15056129
- DOI: 10.1111/j.1462-8902.2004.00335.x
Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome
Abstract
Background: Mild hypoandrogenism in men, usually defined by low levels of testosterone, is a peculiar feature of abdominal obesity that independently predicts the development of insulin resistance and diabetes mellitus. Little is known about the short- and long-term effects of weight loss on sex steroids in abdominally obese men, however.
Objectives: We assessed the effect of rapid weight loss and sustained weight maintenance on the plasma concentrations of testosterone and other sex hormones in 58 abdominally obese men (age, 46.3 +/- 7.5 years; body mass index, 36.1 +/- 3.8 kg/m(2); waist girth, 121 +/- 10 cm) with the metabolic syndrome.
Results: The men lost on average 16.3 +/- 4.5 kg during a 9-week very low-calorie diet (VLCD) and maintained 14.3 +/- 9.1 kg weight loss after a 12-month maintenance period (vs. baseline, p < 0.001). Sex hormone-binding globulin (SHBG) increased from 27.6 +/- 11.9 to 48.1 +/- 23.5 nmol/l during the VLCD but decreased to 32.6 +/- 12.9 nmol/l during weight maintenance, which was still higher than at baseline (p < 0.001). Free testosterone (fT) increased from 185 +/- 66 to 208 +/- 70 pmol/l (p = 0.002) during the VLCD and remained high after 1 year of weight maintenance (212 +/- 84 pmol/l, p = 0.002). Total testosterone levels followed a pattern intermediate between fT and SHBG. Plasma estradiol and dehydroepiandrosterone sulphate concentrations changed only transiently or not at all.
Conclusions: Rapid weight loss with successful weight maintenance in abdominally obese men with the metabolic syndrome brings about a sustained increase in fT levels. The dramatic increase in SHBG attenuated initially during weight maintenance but remained elevated. These findings may be important with regard to prevention of progressive metabolic decompensation and cardiovascular disease associated with obesity and the metabolic syndrome.
Similar articles
-
The effects of metformin and diet on plasma testosterone and leptin levels in obese men.Obes Res. 2001 Nov;9(11):662-7. doi: 10.1038/oby.2001.90. Obes Res. 2001. PMID: 11707532
-
The within-pair resemblance in serum levels of androgens, sex-hormone binding globulin and cortisol in female obese identical twins - effect of negative energy balance induced by very low-calorie diet.Horm Metab Res. 2001 Jul;33(7):417-22. doi: 10.1055/s-2001-16233. Horm Metab Res. 2001. PMID: 11507679 Clinical Trial.
-
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study.Clin Endocrinol (Oxf). 2006 Jul;65(1):125-31. doi: 10.1111/j.1365-2265.2006.02560.x. Clin Endocrinol (Oxf). 2006. PMID: 16817831
-
Does low testosterone affect adaptive properties of adipose tissue in obese men?Arch Physiol Biochem. 2011 Feb;117(1):18-22. doi: 10.3109/13813455.2010.525239. Epub 2010 Nov 12. Arch Physiol Biochem. 2011. PMID: 21073297 Review.
-
Obesity and testicular function.Mol Cell Endocrinol. 2010 Mar 25;316(2):180-6. doi: 10.1016/j.mce.2009.06.007. Epub 2009 Jun 18. Mol Cell Endocrinol. 2010. PMID: 19540307 Review.
Cited by
-
Assessing the Prevalence of Male Obesity-Associated Gonadal Dysfunction in Severe Obesity: A Focus on the Impact of Bariatric Surgery and Surgical Approaches.Obes Surg. 2024 Jul 31. doi: 10.1007/s11695-024-07426-8. Online ahead of print. Obes Surg. 2024. PMID: 39085709
-
Improvements in Sperm Motility Following Low- or High-Intensity Dietary Interventions in Men With Obesity.J Clin Endocrinol Metab. 2024 Jan 18;109(2):449-460. doi: 10.1210/clinem/dgad523. J Clin Endocrinol Metab. 2024. PMID: 37656983 Free PMC article. Clinical Trial.
-
Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology.Cell Mol Life Sci. 2022 Oct 7;79(11):543. doi: 10.1007/s00018-022-04562-1. Cell Mol Life Sci. 2022. PMID: 36205798 Review.
-
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism.Int J Mol Sci. 2022 Jul 25;23(15):8194. doi: 10.3390/ijms23158194. Int J Mol Sci. 2022. PMID: 35897769 Free PMC article. Review.
-
Reply to the letter by Onfiani G. "VLCD versus VLCKD for obese male patients with hypogonadism. Considerations about the recent systematic review and consensus statement published by Italian Society of Endocrinology (SIE)".Eat Weight Disord. 2022 Oct;27(7):2953-2954. doi: 10.1007/s40519-022-01423-5. Epub 2022 May 21. Eat Weight Disord. 2022. PMID: 35596839 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous